Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations

Title
Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations
Authors
Keywords
-
Journal
LUNG CANCER
Volume 72, Issue 2, Pages 205-212
Publisher
Elsevier BV
Online
2010-09-16
DOI
10.1016/j.lungcan.2010.08.013

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search